| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.03e-04 | 1412 | 26 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3.78e-04 | 1459 | 26 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.97e-04 | 120 | 26 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.38e-03 | 654 | 26 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 2.17e-03 | 200 | 26 | 3 | GO:0008237 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 3.54e-05 | 53 | 25 | 3 | GO:0030574 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.04e-04 | 76 | 25 | 3 | GO:0030199 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.26e-04 | 656 | 26 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.28e-04 | 658 | 26 | 6 | GO:0030312 | |
| Domain | - | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 1.18e-08 | 679 | 26 | 10 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 1.44e-08 | 693 | 26 | 10 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 1.46e-08 | 694 | 26 | 10 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 4.15e-08 | 775 | 26 | 10 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 4.25e-08 | 777 | 26 | 10 | PS00028 |
| Domain | Znf_C2H2-like | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 5.33e-08 | 796 | 26 | 10 | IPR015880 |
| Domain | Znf_C2H2 | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 5.93e-08 | 805 | 26 | 10 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 6.14e-08 | 808 | 26 | 10 | SM00355 |
| Domain | PLAC | 2.29e-06 | 19 | 26 | 3 | IPR010909 | |
| Domain | PLAC | 2.29e-06 | 19 | 26 | 3 | PS50900 | |
| Domain | ADAM_spacer1 | 4.16e-06 | 23 | 26 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 4.16e-06 | 23 | 26 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 4.75e-06 | 24 | 26 | 3 | IPR013273 | |
| Domain | KRAB | 9.41e-06 | 369 | 26 | 6 | SM00349 | |
| Domain | KRAB | 9.56e-06 | 370 | 26 | 6 | IPR001909 | |
| Domain | Peptidase_M12B_N | 2.12e-05 | 39 | 26 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.12e-05 | 39 | 26 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.29e-05 | 40 | 26 | 3 | PS00427 | |
| Domain | ADAM_MEPRO | 2.29e-05 | 40 | 26 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.29e-05 | 40 | 26 | 3 | PS50214 | |
| Domain | Reprolysin | 2.29e-05 | 40 | 26 | 3 | PF01421 | |
| Domain | Peptidase_M12B | 2.29e-05 | 40 | 26 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 2.46e-05 | 41 | 26 | 3 | IPR001762 | |
| Domain | zf-C2H2_6 | 6.40e-05 | 314 | 26 | 5 | PF13912 | |
| Domain | TSP_1 | 9.00e-05 | 63 | 26 | 3 | PF00090 | |
| Domain | TSP1 | 9.88e-05 | 65 | 26 | 3 | SM00209 | |
| Domain | TSP1_rpt | 9.88e-05 | 65 | 26 | 3 | IPR000884 | |
| Domain | TSP1 | 9.88e-05 | 65 | 26 | 3 | PS50092 | |
| Domain | KRAB | 1.19e-04 | 358 | 26 | 5 | PS50805 | |
| Domain | KRAB | 1.19e-04 | 358 | 26 | 5 | PF01352 | |
| Domain | MetalloPept_cat_dom | 1.90e-04 | 81 | 26 | 3 | IPR024079 | |
| Domain | - | 1.90e-04 | 81 | 26 | 3 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 3.34e-04 | 98 | 26 | 3 | PS00142 | |
| Domain | EGF_extracell | 3.14e-03 | 60 | 26 | 2 | IPR013111 | |
| Domain | EGF_2 | 3.14e-03 | 60 | 26 | 2 | PF07974 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.84e-05 | 39 | 19 | 3 | MM15165 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.84e-05 | 39 | 19 | 3 | M27417 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 7.11e-05 | 61 | 19 | 3 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.42e-05 | 67 | 19 | 3 | M26999 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 9.84e-05 | 68 | 19 | 3 | M27303 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.37e-04 | 76 | 19 | 3 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.26e-04 | 90 | 19 | 3 | M631 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.98e-04 | 109 | 19 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.20e-04 | 111 | 19 | 3 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 8.79e-04 | 143 | 19 | 3 | M27275 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 8.86e-04 | 33 | 19 | 2 | M39870 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 2.90e-03 | 768 | 19 | 5 | MM14851 | |
| Pathway | PID_IL4_2PATHWAY | 3.30e-03 | 64 | 19 | 2 | M28 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.33e-03 | 250 | 19 | 3 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.73e-03 | 258 | 19 | 3 | MM14572 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 11741898 | ||
| Pubmed | The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology. | 3.71e-10 | 3 | 26 | 3 | 25863161 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 22205175 | ||
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 16556917 | ||
| Pubmed | 3.11e-08 | 9 | 26 | 3 | 31491533 | ||
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 1.68e-07 | 15 | 26 | 3 | 38871984 | |
| Pubmed | Opposing roles for ADAMTS2 and ADAMTS14 in myofibroblast differentiation and function. | 5.37e-07 | 2 | 26 | 2 | 37929635 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 35316211 | ||
| Pubmed | Spontaneous atopic dermatitis due to immune dysregulation in mice lacking Adamts2 and 14. | 5.37e-07 | 2 | 26 | 2 | 29649548 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 24752352 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 26232334 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 31152061 | ||
| Pubmed | ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. | 3.22e-06 | 4 | 26 | 2 | 10094461 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 23491141 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 11831030 | ||
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 32913108 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 28213441 | ||
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 11167130 | ||
| Pubmed | 2.42e-05 | 75 | 26 | 3 | 20637190 | ||
| Pubmed | 6.41e-05 | 16 | 26 | 2 | 31680851 | ||
| Pubmed | 7.26e-05 | 17 | 26 | 2 | 19690890 | ||
| Pubmed | 7.26e-05 | 17 | 26 | 2 | 10464288 | ||
| Pubmed | 1.47e-04 | 24 | 26 | 2 | 29791855 | ||
| Pubmed | Epicardial cell shape and maturation are regulated by Wt1 via transcriptional control of Bmp4. | 3.72e-04 | 38 | 26 | 2 | 31624071 | |
| Pubmed | Novel skin phenotypes revealed by a genome-wide mouse reverse genetic screen. | 6.44e-04 | 50 | 26 | 2 | 24721909 | |
| Cytoband | 19p13.2 | 8.27e-06 | 229 | 26 | 4 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 9.94e-04 | 797 | 26 | 4 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 6.83e-03 | 219 | 26 | 2 | chr7q22 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF407 ZNF322 ZNF799 ZNF605 ZSCAN25 ZNF236 ZNF781 ZNF709 ZNF443 ZNF563 | 2.17e-09 | 718 | 21 | 10 | 28 |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.29e-06 | 19 | 21 | 3 | 50 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.53e-05 | 135 | 26 | 3 | b444005987093efab3265201b3541d7941816cc2 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.00e-04 | 156 | 26 | 3 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 168 | 26 | 3 | 3e3f611e9bbec8224264666be14a4e7db343070e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 169 | 26 | 3 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 172 | 26 | 3 | afa36501d48b1456c511fa0d5d326ec05bdc380f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.48e-04 | 178 | 26 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-04 | 180 | 26 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-04 | 180 | 26 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | PCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.63e-04 | 184 | 26 | 3 | 65cf3460125e3dbc34978957bc138a449f71f7df | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 185 | 26 | 3 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 187 | 26 | 3 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.79e-04 | 190 | 26 | 3 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.82e-04 | 191 | 26 | 3 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 192 | 26 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 192 | 26 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-04 | 193 | 26 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-04 | 194 | 26 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 194 | 26 | 3 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 194 | 26 | 3 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-04 | 194 | 26 | 3 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 194 | 26 | 3 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 198 | 26 | 3 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.03e-04 | 198 | 26 | 3 | 77c81ec602ab553a544c3d9b1e66181b6f000d12 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 199 | 26 | 3 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.06e-04 | 199 | 26 | 3 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.53e-04 | 65 | 26 | 2 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.53e-04 | 65 | 26 | 2 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l32|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.63e-04 | 79 | 26 | 2 | 11e92ae55dae24b6f73dd5a52e1c3c4e579ddf7b | |
| ToppCell | (6)_Macrophage-(61)_LYVE1_Macrophage|(6)_Macrophage / shred on Cell_type and subtype | 1.48e-03 | 98 | 26 | 2 | 30a9a2abd0487e818628db589d31f630ca4d894b | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.54e-03 | 100 | 26 | 2 | f6359e4b3926ce5f0980c994d7271f0743ce4c41 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.54e-03 | 100 | 26 | 2 | 5bbcb307adf73cb8a496773f014d5cf2b36f446c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-Unfolded_protein_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-03 | 107 | 26 | 2 | 7fee0193ee02e9cc62f506660ea7ec23fb4d0c84 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-03 | 125 | 26 | 2 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.50e-03 | 128 | 26 | 2 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-03 | 132 | 26 | 2 | 3661665ed5b257f51530122cb9a9c849b5baa1fb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-03 | 133 | 26 | 2 | b4e68a9a223e5188f1a00c7dc9bb2d675cde1d40 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-03 | 133 | 26 | 2 | 8819fd897b97812355e1709fcc42754522d5fb27 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 2.73e-03 | 134 | 26 | 2 | da3cb572d0c19932619e51e272c0555e91b482ac | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.77e-03 | 135 | 26 | 2 | c7c30b993b3ddac8f1677d5fe47dc2e66d0d26ac | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.81e-03 | 136 | 26 | 2 | feb957df4bff3266cb9a7382b16fc927ae03b9b4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-03 | 139 | 26 | 2 | aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-03 | 139 | 26 | 2 | b9c2dfab119ac0efdf931bb2910e82bccdb4e48d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Malignant_Peripheral_Nerve_Sheath_Tumors|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.10e-03 | 143 | 26 | 2 | d1c8e15a8ae2094de2919e99188f9211b78c5abf | |
| ToppCell | TCGA-Brain-Recurrent_Tumor|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.10e-03 | 143 | 26 | 2 | eeb8ce6e051e18b82b74aaf2fc23f0cb87fc96d5 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.14e-03 | 144 | 26 | 2 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 3.23e-03 | 146 | 26 | 2 | 035393166f3ad5ab95602a8ae11b7d0ee4b1d691 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.23e-03 | 146 | 26 | 2 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.32e-03 | 148 | 26 | 2 | fc80c02b51cf55a04ce550838ee2f41d8f656f41 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.32e-03 | 148 | 26 | 2 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.32e-03 | 148 | 26 | 2 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-03 | 149 | 26 | 2 | 7e295b2b82dea0754e98f8cef788e2781e5d641f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-03 | 149 | 26 | 2 | b4f77dc5f9d08b249fe5cd9a0acf86308c528ef4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.40e-03 | 150 | 26 | 2 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.40e-03 | 150 | 26 | 2 | 1aa9320d97ff10994ea024751790524fe133aba9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-03 | 151 | 26 | 2 | c1461d0dd622a081187eba77f454d2663df2732e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-03 | 152 | 26 | 2 | eee86b508b8f140ea44e21d8c04c409a7b689e39 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.49e-03 | 152 | 26 | 2 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-03 | 153 | 26 | 2 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 3.54e-03 | 153 | 26 | 2 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.54e-03 | 153 | 26 | 2 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.58e-03 | 154 | 26 | 2 | c6ecc46b99a783373729f7fae0b23216148ffb78 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 3.58e-03 | 154 | 26 | 2 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-03 | 154 | 26 | 2 | 1899138c096c08d8aee6b1970b7c0081e14c88a8 | |
| ToppCell | URO-Lymphocyte-T_NK-Treg|URO / Disease, Lineage and Cell Type | 3.58e-03 | 154 | 26 | 2 | 73fe0e26088a1b012902cc062ffbb3e4d2ff09f9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-03 | 154 | 26 | 2 | 9316732964a819a8e935a952faa3823109f90b77 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.58e-03 | 154 | 26 | 2 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.58e-03 | 154 | 26 | 2 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-03 | 157 | 26 | 2 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.72e-03 | 157 | 26 | 2 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 3.77e-03 | 158 | 26 | 2 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.77e-03 | 158 | 26 | 2 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.77e-03 | 158 | 26 | 2 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.77e-03 | 158 | 26 | 2 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-03 | 159 | 26 | 2 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-03 | 159 | 26 | 2 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-03 | 159 | 26 | 2 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.82e-03 | 159 | 26 | 2 | 31ec8222c766cb614e1cf27f74ee9d99489eca5c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-03 | 159 | 26 | 2 | da6b7f8039adc19839d6c090a0b3d68fb6445a79 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.82e-03 | 159 | 26 | 2 | b1d5ebd0c186b6d0279dab20d8f3b4a915acdc1f | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 3.82e-03 | 159 | 26 | 2 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-03 | 160 | 26 | 2 | a76ad44b5f25f59d6b9333fb45f8bb96196a3090 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-03 | 160 | 26 | 2 | af84da18c85037f49f55e8958f00f12140226982 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.86e-03 | 160 | 26 | 2 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-03 | 160 | 26 | 2 | 6005948e400e781cdb876ba350b3ec8991e3945f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-03 | 160 | 26 | 2 | f7ca98beaa24f9674d503588eb15d341c4135d77 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-03 | 161 | 26 | 2 | fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-03 | 161 | 26 | 2 | c53c461fc721a7960cef86662f49e2a495520701 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.91e-03 | 161 | 26 | 2 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-03 | 161 | 26 | 2 | 8d2987271da52fd8353557ac6faa4f7a4be0ed2a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-03 | 161 | 26 | 2 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-03 | 162 | 26 | 2 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-03 | 162 | 26 | 2 | ded08da888d8c481f0f96d1e0bfd03d617966910 | |
| Drug | Oi-1 | 4.61e-08 | 7 | 26 | 3 | CID000448053 | |
| Disease | susceptibility to urinary tract infection measurement | 1.17e-04 | 108 | 26 | 3 | EFO_0008413 | |
| Disease | bipolar disorder (is_marker_for) | 1.26e-04 | 19 | 26 | 2 | DOID:3312 (is_marker_for) | |
| Disease | osteoarthritis (is_implicated_in) | 2.78e-04 | 28 | 26 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | X-12063 measurement | 5.76e-04 | 186 | 26 | 3 | EFO_0021283 | |
| Disease | schizophrenia (is_marker_for) | 6.90e-04 | 44 | 26 | 2 | DOID:5419 (is_marker_for) | |
| Disease | body fat distribution | 7.32e-04 | 202 | 26 | 3 | EFO_0004341 | |
| Disease | obsolete_red blood cell distribution width | 9.37e-04 | 1347 | 26 | 6 | EFO_0005192 | |
| Disease | substance-related disorder | 9.64e-04 | 52 | 26 | 2 | MONDO_0002494 | |
| Disease | coronary artery disease (is_marker_for) | 1.59e-03 | 67 | 26 | 2 | DOID:3393 (is_marker_for) | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 5.03e-03 | 398 | 26 | 3 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | coronary artery calcification | 7.06e-03 | 450 | 26 | 3 | EFO_0004723 | |
| Disease | insomnia, total blood protein measurement | 7.50e-03 | 148 | 26 | 2 | EFO_0004536, EFO_0004698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WCSHPDNPYFCKTKK | 506 | Q8WXS8 | |
| WCSHPDNPYFCKTKK | 516 | O95450 | |
| PVSYKCKCWPGFQLK | 2946 | Q9NZR2 | |
| HTCNVKCPSPVKGYW | 331 | Q15034 | |
| GCPPHWKNFTDKCYY | 606 | Q5KU26 | |
| CGNPSFHLYWPNKKK | 3086 | P78509 | |
| TYFAPTPEACKHLWK | 271 | Q7Z6J6 | |
| WCSHPDNPYFCKTKK | 506 | O15072 | |
| DSKPWYCNKRPSKCF | 16 | Q5JRC9 | |
| QHGPDLYPKFKKWCD | 306 | P36551 | |
| DPKWPSFKKFCCFPF | 556 | Q3KNS1 | |
| KTCCFQYSHKPLPWT | 31 | Q9Y258 | |
| CCKFKHRPWKKYQFP | 631 | Q14028 | |
| SCPAKDWKVHKGKCY | 116 | Q8IZS7 | |
| AKWKTVCAPCPDHYY | 56 | O00300 | |
| PWYCPNCKKHQQATK | 796 | Q13107 | |
| HSSFWKPFQCPECGK | 341 | Q6NSZ9 | |
| EKPYKCSKCEKSFWH | 96 | Q6U7Q0 | |
| PYKCKLCGKAFFWPS | 196 | Q96GE5 | |
| PCHFPCKFSSYEKYW | 481 | P01833 | |
| KPYKCKQCGKAFSWP | 166 | Q8N972 | |
| PYKCKLCGKAFFWPS | 196 | Q8TA94 | |
| PYKCKLCGKAFFWPS | 196 | Q9Y2A4 | |
| WHVCPYCAKEFRKPS | 481 | Q9UL36 | |
| TGEKPFKCTWPTCHY | 1651 | Q9C0G0 | |
| EKPYPCSHCGKAFFW | 306 | Q86T29 | |
| HTGEKPYKCKQCWKA | 111 | Q8N8C0 | |
| PYKCKQCWKAFASVS | 116 | Q8N8C0 |